Neurocrine Biosciences (NBIX) Return on Assets (2011 - 2026)

Neurocrine Biosciences' Return on Assets history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Assets was 0.0% for Q1 2026 at Neurocrine Biosciences, up from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q2 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Neurocrine Biosciences' Return on Assets stood at 0.0% in 2022, then advanced by 20 bps to 0.0% in 2023, then increased by 15 bps to 0.0% in 2024, then grew by 14 bps to 0.0% in 2025, then surged by 30 bps to 0.0% in 2026.
• Business Quant data shows NBIX's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.